Patient who prompted vaccine trial pause developed severe neurological symptoms
A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing.
Full Article
Patient who prompted vaccine trial pause developed severe neurological symptoms
CTV News
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: Western Magnesium, BioSig Technologies, WeedMD, KWESST, Killi, Humanigen UPDATE ...
Proactive Investors
Western Magnesium Corporation (CVE:WMG) (OTCMKTS:MLYF) is building out its first commercialized pilot plant in Canada to become a..
-
AstraZeneca To Resume COVID-19 Vaccine Study After Pause Caused By Serious Symptoms In Patient
Daily Caller
-
Oxford, AstraZeneca resumes coronavirus vaccine trial
SeattlePI.com
-
Oxford, AstraZeneca to resume coronavirus vaccine trial
SeattlePI.com
-
Vaccine trial stopped after neurological symptoms detected
SeattlePI.com
Advertisement
More coverage
Why the AstraZeneca trial for a COVID-19 vaccine was put on hold
WorldNews
Highlights Hold on a trial was second incident for the AstraZeneca candidate vaccine trial Earlier, the AstraZeneca/Oxford trial..